This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Jun 15;403(10444):2596.

doi: 10.1016/S0140-6736(24)01208-X.

No authors listed

Published Erratum

No authors listed. Lancet. 2024.

. 2024 Jun 15;403(10444):2596.

doi: 10.1016/S0140-6736(24)01208-X.

No abstract available

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM, Stock EG, Coric V, Goadsby PJ. Croop R, et al. Lancet. 2021 Jan 2;397(10268):51-60. doi: 10.1016/S0140-6736(20)32544-7. Epub 2020 Dec 15. Lancet. 2021. PMID: 33338437 Clinical Trial.